PDOX News

Updates, happenings and news clips from the AntiCancer PDOX ecosystem. 

DEC 8, 2017: On “The Doctors”: Cancer Screening Saved My Life

Dr. Arun Singh, a Stand up to Cancer researcher and UCLA doctor, joins the panel to share how people can get involved. “Go to getscreenednow.org ...

Read more

NOV 26, 2017: AntiCancer PDOX Roundtable: The Ultimate Personal Medicine Is to Have Your Tumor Modeled

Fritz Eilber, MD and Arun Singh, MD chat with UCLA oncology patient Rachel Young Huff about precision medicine opportunities for patients with in ...

Read more

NOV 19, 2017: AntiCancer PDOX Roundtable: The Paradigm Needs to Be Changed

Fritz Eilber, MD and Arun Singh, MD chat with UCLA oncology patient Rachel Young Huff about the research opportunity for PDOX mouse models. ...

Read more

OCT 24, 2017: AntiCancer PDOX Roundtable: It’s About People

Fritz Eilber, MD and Arun Singh, MD chat with UCLA oncology patient Rachel Young Huff about her PDOX mouse models. ...

Read more

Oct 9, 2017: Patient-Derived Mouse Models of Cancer, by Robert M. Hoffman, Ph.D., now in print!

We literally wrote the book on PDOX. Presently, there is no single source to provide information on technique and uses of mouse models of human ...

Read more

SEPT 1, 2017: In Memory of Rachel Young Huff

Last week we lost a beloved member of the AntiCancer PDOX family. As she participated in our research,Rachel became our close friend. She inspired ...

Read more

AUG 2, 2017: UCLA study provides roadmap to more personalized treatment for soft tissue sarcoma and other aggressive cancers

PDOX has long shown great promise in modeling how sarcoma and other cancers can respond to and resist therapies. A new UCLA study, published in JCO ...

Read more

AUG 2, 2017: AntiCancer PDOX: A Patient’s Story

Rachel — a wife, mother of two, and career woman — chats candidly about her oncology journey at UCLA: “If I didn’t have these ...

Read more

JUNE 26, 2017: SBIR-STTR REPORTS ON NEW AC PDOX CONTRACT

AntiCancer’s history with the Department of Health & Human Service’s Small Business Innovation Research (SBIR) and Small Business ...

Read more

JUNE 3, 2017: PDOX ABSTRACT ACCEPTED AT 2017 ASCO ANNUAL MEETING

Precision medicine for recalcitrant cancers with the patient-derived orthotopic xenograft (PDOX) mouse models for identification of effective ...

Read more

JUNE 2, 2017: ANTICANCER PDOX SHOWCASES SCIENCE PUBLICATIONS AT ASCO17

The ACPDOX team @ASCO17 with a small sampling of our 500+ peer-reviewed precision medicine articles. ...

Read more

JUNE 1, 2017: AntiCancer PDOX: Pre-Clinical Services

AntiCancer PDOX is assisting the world’s leading genetic researchers, pharmaceutical companies and academic laboratories as they undertake new drug ...

Read more

JUNE 1, 2017: ANTICANCER PDOX REACHES SERIES A FINANCING TARGET, APPOINTS BOARD OF DIRECTORS

The new company’s PDOX®-based pre-clinical oncology services will debut at ASCO. Learn More ...

Read more

JUNE 1, 2017: AntiCancer PDOX: Science is a Way of Life

AntiCancer Founder Robert M. Hoffman, PhD, and AntiCancer PDOX Chairman Jim Berglund, explain how they got involved with AntiCancer PDOX. ...

Read more

MAY 12: AC PDOX FOUNDER INVITED TO PRESENT IN POLAND

AC PDOX FOUNDER INVITED TO PRESENT IN POLAND Robert M. Hoffman, PhD, the founder of AntiCancer and AntiCancer PDOX, has been invited to present this ...

Read more

UCLA’S DR. FRITZ EILBER DISCUSSES HIS WORK WITH SARCOMA PATIENTS AND HIGHLIGHTS THE URGENCY OF FINDING THE RIGHT TREATMENT FOR EACH PATIENT.

Two landmark studies are now underway to determine if treatment can benefit the patient after only one cycle. Watch Here ...

Read more

APRIL 5, 2017: DR. THINAR LWIN OF ANTICANCER AND THE UNIVERSITY OF CALIFORNIA AT SAN DIEGO PRESENTS HER POSTER AT AACR THIS WEEK.

The research demonstrates the efficacy of fluorescent imaging in tumor-specific antibody labeling of pancreatic cancer. ...

Read more

APRIL 2, 2017: DAY ONE OF THE AACR ANNUAL MEETING HERE IN WASHINGTON, D.C.

Day One of the AACR Annual Meeting here in Washington, D.C.  Come visit the AntiCancer/PDOX team in Booth #2806 and meet Charlene Cooper, Dr. ...

Read more

MARCH 18, 2017: SSO 2017 ANNUAL CANCER SYMPOSIUM/SEATTLE

Session #70: Tumor Grade & Preoperative Therapy Impact the Establishment of Soft Tissue Sarcoma Patient-Derived Orthotopic Xenografts (PDOX): ...

Read more

MARCH 9, 2017: CANCER FORUM/MUSCULOSKELETAL RESEARCH GROUP TUMOR BOARD PRESENTATION AT UCLA

Cancer Forum/Musculoskeletal Research Group Tumor Board presentation at UCLA     “Tumor Grade & Neoadjuvant Therapy Impact The ...

Read more

MARCH 1, 2017: GLOWING MOUSE PRESENTATION AND TALK/LA JOLLA, CALIF.

For the 10th year, Dr. Robert Hoffman, founder of AntiCancer, Inc., presented to the students at La Jolla (Calif.) High School. Dr. Hoffman is in the ...

Read more

JANUARY 27, 2017: STEPPING UP THE WAR ON CANCER WITH NEW TECHNOLOGY

From Emily Adam at Select Science Stepping up the war on cancer with new technology: Learn how Dr. Robert Hoffman is shifting the paradigm in cancer ...

Read more

NOVEMBER 9, 2016: CONNECTIVE TISSUE ONCOLOGY SOCIETY (CTOS), LISBON, PORTUGAL

“Factors Impacting the Establishment of Individual Soft Tissue Sarcoma Patient-Derived Orthotopic Xenografts (PDOX) Mouse Models: A UCLA Sarcoma ...

Read more